Literature DB >> 31789518

Urea Derivatives in Modern Drug Discovery and Medicinal Chemistry.

Arun K Ghosh1, Margherita Brindisi1,2.   

Abstract

The urea functionality is inherent to numerous bioactive compounds, including a variety of clinically approved therapies. Urea containing compounds are increasingly used in medicinal chemistry and drug design in order to establish key drug-target interactions and fine-tune crucial drug-like properties. In this perspective, we highlight physicochemical and conformational properties of urea derivatives. We provide outlines of traditional reagents and chemical procedures for the preparation of ureas. Also, we discuss newly developed methodologies mainly aimed at overcoming safety issues associated with traditional synthesis. Finally, we provide a broad overview of urea-based medicinally relevant compounds, ranging from approved drugs to recent medicinal chemistry developments.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31789518      PMCID: PMC7266097          DOI: 10.1021/acs.jmedchem.9b01541

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  210 in total

1.  5-HT reuptake inhibitors with 5-HT(1B/1D) antagonistic activity: a new approach toward efficient antidepressants.

Authors:  L Matzen; C van Amsterdam; W Rautenberg; H E Greiner; J Harting; C A Seyfried; H Böttcher
Journal:  J Med Chem       Date:  2000-03-23       Impact factor: 7.446

2.  Discovery of cariprazine (RGH-188): a novel antipsychotic acting on dopamine D3/D2 receptors.

Authors:  Eva Agai-Csongor; György Domány; Katalin Nógrádi; János Galambos; István Vágó; György Miklós Keserű; István Greiner; István Laszlovszky; Anikó Gere; Eva Schmidt; Béla Kiss; Mónika Vastag; Károly Tihanyi; Katalin Sághy; Judit Laszy; István Gyertyán; Mária Zájer-Balázs; Larisza Gémesi; Margit Kapás; Zsolt Szombathelyi
Journal:  Bioorg Med Chem Lett       Date:  2012-04-04       Impact factor: 2.823

Review 3.  Efficacy of oral anticancer agents for colorectal cancer.

Authors:  Junichi Sakamoto; Koji Oba; Takanori Matsui; Michiya Kobayashi
Journal:  Dis Colon Rectum       Date:  2006-10       Impact factor: 4.585

4.  A small molecule-kinase interaction map for clinical kinase inhibitors.

Authors:  Miles A Fabian; William H Biggs; Daniel K Treiber; Corey E Atteridge; Mihai D Azimioara; Michael G Benedetti; Todd A Carter; Pietro Ciceri; Philip T Edeen; Mark Floyd; Julia M Ford; Margaret Galvin; Jay L Gerlach; Robert M Grotzfeld; Sanna Herrgard; Darren E Insko; Michael A Insko; Andiliy G Lai; Jean-Michel Lélias; Shamal A Mehta; Zdravko V Milanov; Anne Marie Velasco; Lisa M Wodicka; Hitesh K Patel; Patrick P Zarrinkar; David J Lockhart
Journal:  Nat Biotechnol       Date:  2005-02-13       Impact factor: 54.908

Review 5.  DNA gyrase, topoisomerase IV, and the 4-quinolones.

Authors:  K Drlica; X Zhao
Journal:  Microbiol Mol Biol Rev       Date:  1997-09       Impact factor: 11.056

6.  Potent urea and carbamate inhibitors of soluble epoxide hydrolases.

Authors:  C Morisseau; M H Goodrow; D Dowdy; J Zheng; J F Greene; J R Sanborn; B D Hammock
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

7.  Antitumor activities of the targeted multi-tyrosine kinase inhibitor lenvatinib (E7080) against RET gene fusion-driven tumor models.

Authors:  Kiyoshi Okamoto; Kotaro Kodama; Kazuma Takase; Naoko Hata Sugi; Yuji Yamamoto; Masao Iwata; Akihiko Tsuruoka
Journal:  Cancer Lett       Date:  2013-07-12       Impact factor: 8.679

8.  Fast and Facile Synthesis of 4-Nitrophenyl 2-Azidoethylcarbamate Derivatives from N-Fmoc-Protected α-Amino Acids as Activated Building Blocks for Urea Moiety-Containing Compound Library.

Authors:  Ying-Ying Chen; Li-Te Chang; Hung-Wei Chen; Chia-Ying Yang; Ling-Wei Hsin
Journal:  ACS Comb Sci       Date:  2017-01-18       Impact factor: 3.784

9.  Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial.

Authors:  Tony W Ho; Michel D Ferrari; David W Dodick; Vince Galet; James Kost; Xiaoyin Fan; Heather Leibensperger; Samar Froman; Christopher Assaid; Christopher Lines; Hille Koppen; Paul K Winner
Journal:  Lancet       Date:  2008-11-25       Impact factor: 79.321

10.  Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia.

Authors:  Michael Andreeff; Kevin R Kelly; Karen Yee; Sarit Assouline; Roger Strair; Leslie Popplewell; David Bowen; Giovanni Martinelli; Mark W Drummond; Paresh Vyas; Mark Kirschbaum; Swaminathan Padmanabhan Iyer; Vivian Ruvolo; Graciela M Nogueras González; Xuelin Huang; Gong Chen; Bradford Graves; Steven Blotner; Peter Bridge; Lori Jukofsky; Steve Middleton; Monica Reckner; Ruediger Rueger; Jianguo Zhi; Gwen Nichols; Kensuke Kojima
Journal:  Clin Cancer Res       Date:  2015-10-12       Impact factor: 12.531

View more
  16 in total

Review 1.  Amide Bond Bioisosteres: Strategies, Synthesis, and Successes.

Authors:  Shikha Kumari; Angelica V Carmona; Amit K Tiwari; Paul C Trippier
Journal:  J Med Chem       Date:  2020-08-04       Impact factor: 7.446

2.  Synthesis and Selective Functionalization of Thiadiazine 1,1-Dioxides with Efficacy in a Model of Huntington's Disease.

Authors:  Leila Terrab; Christopher J Rosenker; Lisa Johnstone; Linh K Ngo; Li Zhang; Nathaniel F Ware; Bettina Miller; Andrea Z Topacio; Sara Sannino; Jeffrey L Brodsky; Peter Wipf
Journal:  ACS Med Chem Lett       Date:  2020-02-20       Impact factor: 4.345

Review 3.  Microbial adaptation and impact into the pesticide's degradation.

Authors:  Sajjad Ahmad; Hafiz Waqas Ahmad; Pankaj Bhatt
Journal:  Arch Microbiol       Date:  2022-04-28       Impact factor: 2.552

4.  Urea-thiazole/benzothiazole hybrids with a triazole linker: synthesis, antimicrobial potential, pharmacokinetic profile and in silico mechanistic studies.

Authors:  Nisha Poonia; Kashmiri Lal; Ashwani Kumar; Anil Kumar; Srikanta Sahu; Anurag T K Baidya; Rajnish Kumar
Journal:  Mol Divers       Date:  2021-10-20       Impact factor: 3.364

5.  Design and Synthesis of Novel Podophyllotoxins Hybrids and the Effects of Different Functional Groups on Cytotoxicity.

Authors:  Zhongtao Yang; Zitong Zhou; Xiai Luo; Xiaoling Luo; Hui Luo; Lianxiang Luo; Weiguang Yang
Journal:  Molecules       Date:  2021-12-30       Impact factor: 4.411

6.  Discovery of novel paeonol-based derivatives against skin inflammation in vitro and in vivo.

Authors:  Jing Wu; Ren De Zhu; Guo Min Cao; Jun Cheng Du; Xin Liu; Liang Zhuo Diao; Zhao Yan Zhang; Yang Sheng Hu; Xin Hua Liu; Jing Bo Shi
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

Review 7.  FDA-Approved Small Molecule Compounds as Drugs for Solid Cancers from Early 2011 to the End of 2021.

Authors:  Aleksandra Sochacka-Ćwikła; Marcin Mączyński; Andrzej Regiec
Journal:  Molecules       Date:  2022-03-31       Impact factor: 4.411

Review 8.  Recent advances in urea- and thiourea-containing compounds: focus on innovative approaches in medicinal chemistry and organic synthesis.

Authors:  Riccardo Ronchetti; Giada Moroni; Andrea Carotti; Antimo Gioiello; Emidio Camaioni
Journal:  RSC Med Chem       Date:  2021-05-13

9.  Copper-Catalyzed Modular Assembly of Polyheterocycles.

Authors:  Qian Wang; Jesse Tuinhof; Kumchok C Mgimpatsang; Katarzyna Kurpiewska; Justyna Kalinowska-Tluscik; Alexander Dömling
Journal:  J Org Chem       Date:  2020-07-12       Impact factor: 4.198

Review 10.  Carbamate group as structural motif in drugs: a review of carbamate derivatives used as therapeutic agents.

Authors:  Ana Matošević; Anita Bosak
Journal:  Arh Hig Rada Toksikol       Date:  2020-12-31       Impact factor: 2.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.